Skip to main content

Table 1 Clinical characteristics of NAFLD patients and normal controls

From: Identifying potential biomarkers of nonalcoholic fatty liver disease via genome-wide analysis of copy number variation

Characteristics

NAFLD (n = 12)

Controls (n = 12)

p-value

Gender (F/M)

9/3

9/3

1

Age (years)

41.33 ± 11.36

41.00 ± 11.33

0.84

WHR

0.92 ± 0.05

0.83 ± 0.04

< 0.001

BMI (kg/m2)

26.83 ± 2.78

21.44 ± 1.70

< 0.001

ALT

45 ± 48.20

12.25 ± 4.50

0.001

AST

28.5 ± 18.48

19.5 ± 2.84

0.31

TC

5.81 ± 0.70

4.67 ± 0.28

< 0.001

TG

2.07 ± 1.18

0.82 ± 0.24

< 0.001

FBG

5.57 ± 0.67

4.98 ± 0.33

0.009

LDL-C

3.73 ± 0.63

2.97 ± 0.18

0.001

HDL-C

1.29 ± 0.18

1.33 ± 0.21

0.435

  1. BMI body mass index, WHR waist-to-hip ratio, AST serum aspartate aminotransferase, ALT alanine aminotransferase, GGT gamma-glutamyltranspeptidase, FBG serum fasting glucose, TC total cholesterol, TG triglycerides, LDL-C low-density lipoprotein, HDL-C high-density lipoprotein